GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization

被引:27
作者
Dautzenberg, FM
Wille, S
Braun, S
Hauger, RL
机构
[1] Hoffmann La Roche Ag, Div Pharma, CH-4070 Basel, Switzerland
[2] Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany
[3] Univ Calif San Diego, VA Health Syst, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S0006-291X(02)02463-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The EC50 values for concentration-dependent stimulation of cAMP accumulation by CRF (1.3 nM) and urocortin (1.0 nM) were equivalent in human retinoblastoma Y79 cells. The time course and magnitude of CRF- and urocortin-induced CRF, receptor desensitization were similar. A significant 3-fold increase in GRK3, but not GRK2, mRNA levels accompanied the emergence of CRF1 receptor desensitization in Y79 cells exposed to CRF. In preliminary experiments, retinoblastoma GRK3 protein expression became upregulated during a 48-h CRF expo sure. Neither GRK3 nor GRK2 expression increased in Y79 cells exposed to urocortin for 10 min to 48 It. We hypothesize that GRK3 upregulation may be a cellular negative feedback process directed at maximizing CRF1 receptor desensitization by heightening GRK3 phosphorylating capacity during prolonged exposure to high CRF. Regulation of GRK expression associated with urocortin- and CRF-induced CRF1 receptor desensitization appears to differ, despite a similar level of signaling via the cAMP-protein kinase A pathway. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 38 条
[1]  
BAWA T, 2002, PHARMACOLOGIST, V44, pA198
[2]   Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system [J].
Bittencourt, JC ;
Sawchenko, PE .
JOURNAL OF NEUROSCIENCE, 2000, 20 (03) :1142-1156
[3]   Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase [J].
Choi, DJ ;
Koch, WJ ;
Hunter, JJ ;
Rockman, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :17223-17229
[4]   Endocytosis of G protein-coupled receptors:: roles of G protein-coupled receptor kinases and β-arrestin proteins [J].
Claing, A ;
Laporte, SA ;
Caron, MG ;
Lefkowitz, RJ .
PROGRESS IN NEUROBIOLOGY, 2002, 66 (02) :61-79
[5]   Partial agonists and G protein-coupled receptor desensitization [J].
Clark, RB ;
Knoll, BJ ;
Barber, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) :279-286
[6]  
Dautzenberg F. M., 1998, Society for Neuroscience Abstracts, V24, P613
[7]   The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile [J].
Dautzenberg, FM ;
Kilpatrick, GJ ;
Wille, S ;
Hauger, RL .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :821-829
[8]   G-protein-coupled receptor kinase 3-and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells [J].
Dautzenberg, FM ;
Hauger, RL .
NEUROPHARMACOLOGY, 2001, 40 (03) :394-407
[9]  
Dautzenberg FM, 2001, J PHARMACOL EXP THER, V298, P812
[10]   GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation [J].
Dautzenberg, FM ;
Braun, S ;
Hauger, RL .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (04) :R935-R946